In Brief: St. Jude
This article was originally published in The Gray Sheet
Executive Summary
St. Jude: Initial implants of the firm's Angstrom MD and Contour MD implantable cardioverter defibrillator devices are performed in two patients Oct. 17 at the University of Kentucky Hospital, Lexington, following St. Jude's Oct. 2 receipt of an investigational device exemption to study the morphology detection technology incorporated in the single-lead ICD systems. The morphology detection algorithm enables the device to discriminate between atrial arrhythmias and ventricular arrhythmias "based on the characteristics of their electrogram complexes," St. Jude claims. The U.S. study will consist of 20 sites and will enroll 65 patients. European trials of the devices are ongoing ("The Gray Sheet" June 23, I&W-6)...